CVS Group plc buy tbackenh
Start price
20.12.23
/
80%
€19.10
Target price
01.04.25
€23.00
Performance (%)
-35.60%
End price
22.02.25
€12.30
Summary
This prediction ended on 22.02.25 with a price of €12.30. Massive losses of -35.60% were the result for the BUY prediction by tbackenh. tbackenh has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CVS Group plc | -0.725% | -0.725% | 35.644% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
According to tbackenh what are the pros and cons of CVS Group plc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
positive Cash Flow expected
Good rating
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Known brand
Cons
Comments by tbackenh for this prediction
In the thread CVS Group plc diskutieren
Britisches Unternehmen, das tierärztliche Dienstleistungen anbietet. Insgesamt über 8.500 Mitarbeiter